Integral Health Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Integral Health Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,000	Closed	-$6.1M	–	78
2025 Q1	$6.1M	Sell	100,000 -250,000	-71%	-$14.6M	0.65%	45
2024 Q4	$19.8M	Buy	350,000 +175,000	+100%	+$9.78M	1.69%	18
2024 Q3	$9.05M	Buy	+175,000	New	+$8.21M	1.02%	28
2021 Q2	–	Sell	-50,000	Closed	-$3.16M	–	75
2021 Q1	$3.16M	Buy	+50,000	New	+$3.11M	0.9%	42
2020 Q4	–	Sell	-50,000	Closed	-$3.02M	–	61
2020 Q3	$3.02M	Sell	50,000 -150,000	-75%	-$9.03M	0.92%	39
2020 Q2	$11.8M	Buy	200,000 +25,000	+14%	+$1.5M	3.52%	3
2020 Q1	$9.76M	Sell	175,000 -15,000	-8%	-$917K	4.3%	4
2019 Q4	$12.2M	Buy	+190,000	New	+$10.9M	4.75%	3

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Integral Health Asset Management's BMY Position: Q2 2025 in Review

Integral Health Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 100,000 shares — an estimated $6.1M sold.

Integral Health Asset Management first reported a position in BMY in Q4 2019 and held it in 8 quarters. The position peaked at $19.8M in Q4 2024. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Integral Health Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Integral Health Asset Management sold 100,000 Bristol-Myers Squibb shares in Q2 2025, an estimated $6.1M.
Integral Health Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 8 quarters.
Integral Health Asset Management's Bristol-Myers Squibb position peaked at $19.8M in Q4 2024.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Integral Health Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.